Skip to main content
Top
Published in: Diagnostic Pathology 1/2018

Open Access 01-12-2018 | Research

No evidence for human papillomavirus having a causal role in salivary gland tumors

Authors: Linnea Haeggblom, Ramona Gabriela Ursu, Leila Mirzaie, Tove Attoff, Caroline Gahm, Lalle Hammarstedt Nordenvall, Anders Näsman

Published in: Diagnostic Pathology | Issue 1/2018

Login to get access

Abstract

Background

Salivary gland malignancies are a very heterogeneous group of cancers, with histologically > 20 different subtypes, and prognosis varies greatly. Their etiology is unknown, however, a few small studies show presence of human papillomavirus (HPV) in some subtypes, although the evidence for HPV having a causal role is weak. The aim of this study was to investigate if HPV plays a causal role in the development of different parotid salivary gland tumor subtypes.

Methods

DNA was extracted from 107 parotid salivary gland formalin fixed paraffin embedded tumors and 10 corresponding metastases, and tested for 27 different HPV types using a multiplex bead based assay. HPV DNA positive tumors were stained for p16INK4a overexpression by immunohistochemistry.

Results

One of the 107 malignant parotid salivary gland tumors (0.93%) and its corresponding metastasis on the neck were positive for HPV16 DNA, and both also overexpressed p16INK4a. The HPV positive primary tumor was a squamous cell carcinoma; neither mucoepidermoid nor adenoid cystic tumors were found HPV positive.

Conclusions

In conclusion, HPV DNA analysis in a large number of malignant parotid salivary gland tumors, including 12 different subtypes, did not show any strong indications that tested HPV types have a causal role in the studied salivary gland tumor types.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gillespie MB, Albergotti WG, Eisele DW. Recurrent salivary gland cancer. Curr Treat Options in Oncol. 2012;13:58–70.CrossRef Gillespie MB, Albergotti WG, Eisele DW. Recurrent salivary gland cancer. Curr Treat Options in Oncol. 2012;13:58–70.CrossRef
2.
go back to reference Barnes L, Eveson JW, Peter Reichart DS. WHO classification of Tumours. Pathol Genet Head Neck Tumours. 2005;9:209–81. Barnes L, Eveson JW, Peter Reichart DS. WHO classification of Tumours. Pathol Genet Head Neck Tumours. 2005;9:209–81.
4.
go back to reference Dahlstrand HM, Dalianis T. Presence and influence of human papillomaviruses (HPV) in tonsillar cancer. Adv Cancer Res. 2005;93:59–89.CrossRefPubMed Dahlstrand HM, Dalianis T. Presence and influence of human papillomaviruses (HPV) in tonsillar cancer. Adv Cancer Res. 2005;93:59–89.CrossRefPubMed
5.
go back to reference International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 90. Lyon, France: Human papillomaviruses; 2007. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 90. Lyon, France: Human papillomaviruses; 2007.
8.
go back to reference Lindquist D, Romanitan M, Hammarstedt L, Näsman A, Dahlstrand H, Lindholm J, et al. Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol. 2007;1:350–5.CrossRefPubMedPubMedCentral Lindquist D, Romanitan M, Hammarstedt L, Näsman A, Dahlstrand H, Lindholm J, et al. Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol. 2007;1:350–5.CrossRefPubMedPubMedCentral
10.
go back to reference Isayeva T, Li Y, Maswahu D, Brandwein-Gensler M. Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol. 2012;6(SUPPL. 1):104–20.CrossRefPubMedCentral Isayeva T, Li Y, Maswahu D, Brandwein-Gensler M. Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol. 2012;6(SUPPL. 1):104–20.CrossRefPubMedCentral
12.
go back to reference Vageli D, Sourvinos G, Ioannou M, Koukoulis GK, Spandidos DA. High-risk human papillomavirus (HPV) in parotid lesions. Int J Biol Markers. 2007;22:239–44.CrossRefPubMed Vageli D, Sourvinos G, Ioannou M, Koukoulis GK, Spandidos DA. High-risk human papillomavirus (HPV) in parotid lesions. Int J Biol Markers. 2007;22:239–44.CrossRefPubMed
13.
go back to reference Skalova A, Kaspirkova J, Andrle P, Hosticka L, Vanecek T. Human papillomaviruses are not involved in the etiopathogenesis of salivary gland tumors. Ces Patol. 2013;49:72–5. Skalova A, Kaspirkova J, Andrle P, Hosticka L, Vanecek T. Human papillomaviruses are not involved in the etiopathogenesis of salivary gland tumors. Ces Patol. 2013;49:72–5.
14.
go back to reference Hafed L, Farag H, Shaker O, El-Rouby D. Is human papilloma virus associated with salivary gland neoplasms? An in situ-hybridization study. Arch Oral Biol. 2012;57:1194–9.CrossRefPubMed Hafed L, Farag H, Shaker O, El-Rouby D. Is human papilloma virus associated with salivary gland neoplasms? An in situ-hybridization study. Arch Oral Biol. 2012;57:1194–9.CrossRefPubMed
15.
go back to reference Lin FC, Chen PL, Tsao TY, Li CR, Jeng KC, Tsai SC. Prevalence of human papillomavirus and Epstein-Barr virus in salivary gland diseases. J Int Med Res. 2014;42:1093–101.CrossRefPubMed Lin FC, Chen PL, Tsao TY, Li CR, Jeng KC, Tsai SC. Prevalence of human papillomavirus and Epstein-Barr virus in salivary gland diseases. J Int Med Res. 2014;42:1093–101.CrossRefPubMed
17.
go back to reference Xu B, Wang L, Borsu L, Ghossein R, Katabi N, Ganly I, et al. A proportion of primary squamous cell carcinomas of the parotid gland harbour high-risk human papillomavirus. Histopathology. 2016;69:921–9.CrossRefPubMedPubMedCentral Xu B, Wang L, Borsu L, Ghossein R, Katabi N, Ganly I, et al. A proportion of primary squamous cell carcinomas of the parotid gland harbour high-risk human papillomavirus. Histopathology. 2016;69:921–9.CrossRefPubMedPubMedCentral
18.
go back to reference Schmitt M, Dondog B, Waterboer T, Pawlita M. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J Clin Microbiol. 2008;46:1050–9.CrossRefPubMedPubMedCentral Schmitt M, Dondog B, Waterboer T, Pawlita M. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J Clin Microbiol. 2008;46:1050–9.CrossRefPubMedPubMedCentral
22.
go back to reference Sivars L, Näsman A, Tertipis N, Vlastos A, Ramqvist T, Dalianis T, et al. Human papillomavirus and p53 expression in cancer of unknown primary in the head and neck region in relation to clinical outcome. Cancer Med. 2014;3:376–84.CrossRefPubMedPubMedCentral Sivars L, Näsman A, Tertipis N, Vlastos A, Ramqvist T, Dalianis T, et al. Human papillomavirus and p53 expression in cancer of unknown primary in the head and neck region in relation to clinical outcome. Cancer Med. 2014;3:376–84.CrossRefPubMedPubMedCentral
23.
go back to reference Begum S, Gillison ML, Ansari-Lari MA, Shah K, Westra WH. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res. 2003;9:6469–75.PubMed Begum S, Gillison ML, Ansari-Lari MA, Shah K, Westra WH. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res. 2003;9:6469–75.PubMed
Metadata
Title
No evidence for human papillomavirus having a causal role in salivary gland tumors
Authors
Linnea Haeggblom
Ramona Gabriela Ursu
Leila Mirzaie
Tove Attoff
Caroline Gahm
Lalle Hammarstedt Nordenvall
Anders Näsman
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2018
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/s13000-018-0721-0

Other articles of this Issue 1/2018

Diagnostic Pathology 1/2018 Go to the issue